期刊文献+

腺苷脱氨酶、癌胚抗原和结核抗体检测对鉴别良、恶性胸腔积液的诊断价值

Rescearch on Adenosine Deaminase,Carcinoembryonic Antigen,and Tuberculosis Antibody Detection in the Different Diagnosing Benign and Malignant Pleural Effusion
下载PDF
导出
摘要 目的:评价腺苷脱氨酶(ADA)、癌胚抗原(CEA)、结核抗体(TB-Ab)对鉴别良、恶性胸腔积液的诊断价值。方法:检测126例结核性胸腔积液、58例恶性胸腔积液患者胸水中的ADA、CEA、TB-Ab水平。结果:结核组胸水中ADA水平明显高于恶性组(P<0.01);恶性组胸水CEA水平明显高于结核组(P<0.01);CEA在结核性和癌性胸腔积液中的阳性率分别为7.9%和58.6%,特异性为92.1%,TB-Ab在结核性和癌性胸腔积液中的阳性率分别为78.6%和8.6%,特异性为91.4%;以P-ADA>40U/L为诊断结核的临界值,其敏感性为77.8%,特异性为84.5%。结论:测定胸水ADA、CEA和TB-Ab水平是鉴别良、恶性胸腔积液的重要方法之一。 Objective:To evaluate tadenosine deaminase(ADA),carcinoembryonic antigen(CEA),tuberculosis antibody(TB-Ab) in the differentiating benign and malignant pleural effusion.Methods:The ADA,CEA and TB-Ab levels of 126 patients with tuberculous pleural effusion and 58 patients with malignant pleural effusion were detected.Results:The ADA levels of pleural fluid in the TB group was significantly higher than in the malignant group(P〈0.01);The CEA levels of pleural fluid in the malignant group was significantly higher than in the TB group(P〈0.01).The positive rate of CEA is 7.9% in tuberculous pleural effusion and 58.6% in malignant pleural effusion,and the specificity is 92.1%;the positive rate of TB-Ab is 78.6% in tuberculous pleural effusion and 8.6% in malignant pleural effusion,and the specificity is 91.4%;the sensitivity is 77.8% and the specificity is 84.5% on the basis of P-ADA 40U /L threshold for the diagnosis of tuberculosis.Conclusion:The determination of pleural fluid ADA,CEA,and TB-Ab levels is one important way in differentiating benign and malignant pleural effusion.
作者 李娜 邱珊
机构地区 兰州市肺科医院
出处 《甘肃中医》 2010年第8期12-13,共2页 Gansu Journal of Traditional Chinese Medicine
关键词 腺苷脱氨酶 癌胚抗原 结核抗体 胸腔积液 恶性 胸腔积液 良性 诊断鉴别 adenosine deaminase carcinoembryonic antigen tuberculosis antibody malignant pleural effusion benign pleural effusion differential diagnosis
  • 相关文献

参考文献5

  • 1Ando S,Kimura H,Iwai N,et al.Optimal combination of seven tumor marers in prediction of advanced stage at first examnation of patients with non-small cell lung cancer[J].Anticancer Res,2001,21(4B):3085-3092.
  • 2况成明,陈启福.三种肿瘤标记物联合检测对肺癌临床应用价值的探讨[J].中国肿瘤临床,2000,27(5):388-388. 被引量:40
  • 3吴广平,巴静,王恩华,滕月娥,范霞.检测胸水中CEA、CA125、CA153及CA199对肺癌的诊断价值[J].中国肺癌杂志,2004,7(1):35-37. 被引量:75
  • 4Lamsal M,uatam N,Bhatta N,et al.Diagnostic utility of adenosine deaminase(ADA)activity in pleural fluid and serum of tuberculous and non-tubercilous respi-ratory disease patients[J].southeast asian J tropmed public Health,2007,38(2):363-369.
  • 5张本 王忠仁 宋礼章 整理.中华医学会第九次全国结核病学术会议记要.中华结核和呼吸杂志,1996,(19):375-376.

二级参考文献8

  • 1[1]Fuhrman C, Duche JC, Chouaid C, et al. Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies. Clin Biochem,2000,33(5):405-410.
  • 2[2]Alatas F, Alatas O, Metintas M, et al. Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions. Lung Cancer,2001,31(1):9-16.
  • 3[3]Miedouge M, Rouzaud P, Salama G, et al. Evaluation of seven tumor markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer,1999,81(6):1059-1065.
  • 4[4]Ando S, Kimura H, Iwai N, et al. Optimal combination of seven tumor markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Anticancer Res,2001,21(4B):3085-3092.
  • 5[5]Kulpa J, Wojcik E, Reinfuss M, et al. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Clin Chem,2002,48(11):1931-1937.
  • 6[6]Salgia R, Harpole D, Herndon JE 2nd, et al. Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer. Anticancer Res,2001,21(2B):1241-1246.
  • 7[9]Romero S, Fernandez C, Arriero JM, et al. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions. Eur Respir J,1996,9(1):17-23.
  • 8[10]Toumbis M, Rasidakis A, Passalidou E, et al. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions. Anticancer Res,1996,16(4A):2101-2104.

共引文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部